Bausch Health Companies Future Growth
Future criteria checks 3/6
Bausch Health Companies is forecast to grow earnings and revenue by 91% and 1.8% per annum respectively while EPS is expected to grow by 97.7% per annum.
Key information
91.0%
Earnings growth rate
97.7%
EPS growth rate
Pharmaceuticals earnings growth | 23.4% |
Revenue growth rate | 1.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation
Feb 24Bausch Health: $20bn Debt Is A Mighty Elephant In The Room
Nov 30Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?
Nov 01Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics
Sep 24Is Bausch Health Companies (NYSE:BHC) A Risky Investment?
Jul 24Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes
Jul 06What To Do After Bausch Health Stock Plunged By Nearly 9% Again
Jun 07Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt
Apr 18Bausch Health: A Basket Case Of A Business Only A Hedge Fund Can Bail Out
Dec 30Bausch Health acne lotion Arazlo available in Canada under public drug plans
Dec 22Bausch Health: Things To Consider Before Investing
Dec 11Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues
Nov 10Bausch Health Companies Q3 2022 Earnings Preview
Nov 02Bausch Health: Long-Term Need To Place Stops For Protection
Sep 28Bausch Health Companies: Equity Stub Would Benefit From Ambitious Spinoff
Sep 21Bausch Health sheds 10% as FDA grants tentative approval for Xifaxan generic
Sep 08Bausch Health begin offers to exchange debt up to $4B
Aug 31Bausch Health Stock Down 11%: Now What?
Aug 09Bausch Health: How To Price The Calamities
Jul 31Bausch Health: Uncertain, Far From Healthy, But Potentially Lucrative
Jul 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 9,934 | 432 | N/A | N/A | 5 |
12/31/2025 | 9,643 | 389 | 1,348 | N/A | 6 |
12/31/2024 | 9,385 | 240 | 1,041 | N/A | 7 |
3/31/2024 | 8,966 | -455 | N/A | N/A | N/A |
12/31/2023 | 8,757 | -592 | 760 | 1,032 | N/A |
9/30/2023 | 8,542 | -963 | 893 | 1,117 | N/A |
6/30/2023 | 8,350 | -186 | -665 | -428 | N/A |
3/31/2023 | 8,150 | -357 | -773 | -511 | N/A |
12/31/2022 | 8,124 | -225 | -996 | -728 | N/A |
9/30/2022 | 8,127 | 254 | -1,434 | -1,179 | N/A |
6/30/2022 | 8,192 | 43 | 384 | 648 | N/A |
3/31/2022 | 8,325 | -407 | 648 | 920 | N/A |
12/31/2021 | 8,434 | -948 | 1,143 | 1,426 | N/A |
9/30/2021 | 8,451 | -1,170 | 1,512 | 1,796 | N/A |
6/30/2021 | 8,478 | -1,287 | 1,190 | 1,488 | N/A |
3/31/2021 | 8,042 | -1,018 | 988 | 1,293 | N/A |
12/31/2020 | 8,027 | -560 | 802 | 1,111 | N/A |
9/30/2020 | 8,038 | -1,923 | 641 | 951 | N/A |
6/30/2020 | 8,109 | -2,043 | 899 | 1,210 | N/A |
3/31/2020 | 8,597 | -1,888 | 1,046 | 1,349 | N/A |
12/31/2019 | 8,601 | -1,788 | 1,223 | 1,501 | N/A |
9/30/2019 | 8,498 | -616 | 1,329 | 1,586 | N/A |
6/30/2019 | 8,425 | -917 | 1,386 | 1,593 | N/A |
3/31/2019 | 8,401 | -1,619 | 1,241 | 1,476 | N/A |
12/31/2018 | 8,380 | -4,148 | 1,266 | 1,501 | N/A |
9/30/2018 | 8,422 | -3,291 | 1,517 | 1,760 | N/A |
6/30/2018 | 8,505 | -1,640 | 170 | 1,728 | N/A |
3/31/2018 | 8,610 | -805 | 260 | 1,774 | N/A |
12/31/2017 | 8,724 | 2,404 | N/A | 2,290 | N/A |
9/30/2017 | 8,964 | 1,376 | N/A | 2,224 | N/A |
6/30/2017 | 9,224 | -1,143 | N/A | 2,304 | N/A |
3/31/2017 | 9,411 | -1,407 | N/A | 2,484 | N/A |
12/31/2016 | 9,674 | -2,409 | N/A | 2,087 | N/A |
9/30/2016 | 10,024 | -2,280 | N/A | 2,172 | N/A |
6/30/2016 | 10,332 | -1,013 | N/A | 2,360 | N/A |
3/31/2016 | 10,644 | -764 | N/A | 2,323 | N/A |
12/31/2015 | 10,442 | -292 | N/A | 2,257 | N/A |
9/30/2015 | 9,906 | 596 | N/A | 2,476 | N/A |
6/30/2015 | 9,175 | 822 | N/A | 2,336 | N/A |
3/31/2015 | 8,484 | 1,001 | N/A | 2,302 | N/A |
12/31/2014 | 8,200 | 881 | N/A | 2,312 | N/A |
9/30/2014 | 8,043 | 502 | N/A | 1,759 | N/A |
6/30/2014 | 7,529 | -746 | N/A | 1,342 | N/A |
3/31/2014 | 6,583 | -861 | N/A | 1,271 | N/A |
12/31/2013 | 5,766 | -866 | N/A | 1,042 | N/A |
9/30/2013 | 4,626 | -1,079 | N/A | 830 | N/A |
6/30/2013 | 3,968 | -98 | N/A | 795 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BHC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: BHC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BHC is expected to become profitable in the next 3 years.
Revenue vs Market: BHC's revenue (1.8% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: BHC's revenue (1.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BHC's Return on Equity is forecast to be high in 3 years time